All News
COVID: DMARDs, Steroids, a Vaccine - and how long will this continue?
Dr. Kevin Winthrop reviews all things COVID-related including abstract L01 from the 2020 ACR Convergence, steroids and DMARDs, vaccination status - and how long this pandemic will last.
Read Article
COVID and Rheumatic Disease Patients: Dr. Kevin Winthrop
Portland-based Dr. Kevin Winthrop from OHSU discusses Saturday ACR 2020 posters #0623 and #0629 related to COVID-19 and rheumatic disease patients.
Read Article
How COVID Changed Work: Drs. Rachel Tate, Cassie Calabrese and Mary Hinojos Mamut #ACR20
https://t.co/jyM8NPicZF https://t.co/6zA7Kmgzwi
Links:
Dr. John Cush RheumNow ( View Tweet)
Worth the read!
My Experience as a COVID19 Vaccine Trial Participant by Dr. Kathryn Dao ( @KDAO2011)
https://t.co/ILfXLUL8IZ https://t.co/7parTGPllu
Links:
Dr. John Cush RheumNow ( View Tweet)
Timely video on COVID 19 and Rheumatic Disease with Dr. Jeffrey Sparks ( @jeffsparks) #acr20
https://t.co/5Qg3HRkQyW
Links:
Dr. John Cush RheumNow ( View Tweet)
Timely video on COVID 19 and Rheumatic Disease with Dr. Jeffrey Sparks ( @jeffsparks) #acr20
https://t.co/5Qg3HRkQyW https://t.co/x0iQ6XX3eJ
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @doctorRBC : Tocilizumab NOT effective in preventing mechanical ventilation or death in moderately ill COVID-19 pts.
Double-blind, Placebo, RCT (n=243)
@RheumNow #ACR20 Abs#L07 #ACRbest https://t.co/Gi5FpodeKf https://t.co/bTk8n7dNni
Links:
Dr. John Cush RheumNow ( View Tweet)
Video:COVID and Rheumatic Disease Patients with Dr. Kevin Winthrop #ACR20
https://t.co/VHIibPNDXG https://t.co/0OVIXzX6su
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @synovialjoints : About half (51%) of patients from the FORWARD registry in the US had at least one telehealth appointment during COVID-19 pandemic and most were satisfied with the appointment @RheumNow #ACR20 Abstr#1962 https://t.co/PEiucSItZq https://t.co/6vzIlQWjOP
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @synovialjoints : About half (51%) of patients from the FORWARD registry in the US had at least one telehealth appointment during COVID-19 pandemic and most were satisfied with the appointment #ACR20 Abstr#1962 https://t.co/PEiucSItZq https://t.co/Z2qRaWDRaN
Links:
Dr. John Cush RheumNow ( View Tweet)
Six Things Rheumatologists Need to Know About COVID-19 by Dr. Rachel Tate ( @uptoTate) #ACR20
https://t.co/RUWDexA3Qc https://t.co/Psd8V60XxO
Links:
Dr. John Cush RheumNow ( View Tweet)
COVID: DMARDs, Steroids, a Vaccine - and how long will this continue? #ACR20
https://t.co/UHKxNcpojh https://t.co/0rvOmEVrK7
Links:
Dr. John Cush RheumNow ( View Tweet)
A Convergence of Ideas: COVID19 and ACR by Dr. Kathryn Dao (@KDAO2011) #ACR20 https://t.co/95Y3ilCwyq https://t.co/Oje9vcbHnt
Links:
Dr. John Cush RheumNow ( View Tweet)
Watch our video titled "Outcomes for Rheumatic Disease Patients with COVID-19" with Dr Kathryn Dao ( @KDAO2011) #ACR20
https://t.co/771RLB0pqA https://t.co/glr98MQHac
Links:
Dr. John Cush RheumNow ( View Tweet)
Telemedicine Studies: A Trainee’s Perspective by Mrinalini Dey ( @DrMiniDey ) COVID-19 has shifted face to face to consultations--an important change in rheumatology practice. #ACR20 https://t.co/IzvyeFC8w8 https://t.co/SIQxfuUuEk
Links:
Dr. John Cush RheumNow ( View Tweet)
Moderna mRNA-1273 vaccine, developed for COVID-19, yielded 94.5% efficacy in early results of the phase 3 COVE trial. 90 who were COVID-19 pos were in a placebo group and that 5 patients were in the mRNA-1273 vaccine group. https://t.co/9245wj3kph
Links:
Dr. John Cush RheumNow ( View Tweet)
AI, COVID and metabolomics are among the top subjects Dr. Arthur Kavanaugh previews in this opening perspective of #ACR20.
https://t.co/rE4uPDGRUK https://t.co/ei00a1jw2B
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Janet Pope ( @Janetbirdope) meets with several rheumatology trainees to discuss training and education in this COVID-19 era. Interviewees includes Drs. Arpat Gantayet, Gabriel Jeyasingham, Gemma Cramarossa and Melissa Holdren. #ACR20
https://t.co/YSitDviOon https://t.co/NGWaEtzyMR
Links:
Dr. John Cush RheumNow ( View Tweet)
Curious how COVID-19 affects rheumatic patients? Dr. Jeffrey Sparks ( @jeffsparks) is answering some top questions. #ACR20
https://t.co/Pd1gZa1o6f https://t.co/OVTqLeYI8q
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out this video with Dr. Dey (@DrMiniDey) on race/ethnicity associated with poor outcomes in rheum patients with COVID-19 ) #ACR20
https://t.co/ecenB2i5At
Links:
Dr. John Cush RheumNow ( View Tweet)
